Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 23;13(5):851.
doi: 10.3390/diagnostics13050851.

Advanced Autoantibody Testing in Systemic Sclerosis

Kholoud Almaabdi  1 , Zareen Ahmad  1 , Sindhu R Johnson  1   2   3
Affiliations
Review

Advanced Autoantibody Testing in Systemic Sclerosis

Kholoud Almaabdi et al. Diagnostics (Basel). .

Abstract

Systemic sclerosis is a systemic autoimmune rheumatic disease characterized by immune abnormalities, leading to vasculopathy and fibrosis. Autoantibody testing has become an increasingly important part of diagnosis and prognostication. Clinicians have been limited to antinuclear antibody (ANA), antitopoisomerase I (also known as anti-Scl-70) antibody, and anticentromere antibody testing. Many clinicians now have improved access to an expanded profile of autoantibody testing. In this narrative review article, we review the epidemiology, clinical associations, and prognostic value of advanced autoantibody testing in people with systemic sclerosis.

Keywords: antibodies; scleroderma; systemic sclerosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Distler O., Assassi S., Cottin V., Cutolo M., Danoff S.K., Denton C.P., Distler J.H., Hoffmann-Vold A.-M., Johnson S.R., Ladner U.M., et al. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur. Respir. J. 2020;55:1902026. doi: 10.1183/13993003.02026-2019. - DOI - PMC - PubMed
    1. Ruaro B., Soldano S., Smith V., Paolino S., Contini P., Montagna P., Pizzorni C., Casabella A., Tardito S., Sulli A., et al. Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: A pilot study. Rheumatol. Int. 2019;39:1369–1376. doi: 10.1007/s00296-019-04315-7. - DOI - PubMed
    1. Caforio A.L.P., De Luca G., Baritussio A., Seguso M., Gallo N., Bison E., Cattini M.G., Pontara E., Gargani L., Pepe A., et al. Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates. Diagnostics. 2021;11:2165. doi: 10.3390/diagnostics11112165. - DOI - PMC - PubMed
    1. Ruaro B., Baratella E., Confalonieri P., Wade B., Marrocchio C., Geri P., Busca A., Pozzan R., Andrisano A.G., Cova M.A., et al. High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients. Diagnostics. 2021;11:1960. doi: 10.3390/diagnostics11111960. - DOI - PMC - PubMed
    1. Bairkdar M., Rossides M., Westerlind H., Hesselstrand R., Arkema E.V., Holmqvist M. Incidence and prevalence of systemic sclerosis globally: A comprehensive systematic review and meta-analysis. Rheumatology. 2021;60:3121–3133. doi: 10.1093/rheumatology/keab190. - DOI - PMC - PubMed